Trials / Completed
CompletedNCT01329380
Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)
Special Investigation (All Cases Investigation in Patients With Ankylosing Spondylitis)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 403 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 16 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This study of adalimumab (Humira) will be conducted to clarify the following with regard to the treatment of ankylosing spondylitis with this drug: * Unknown adverse drug reactions (especially important adverse drug reactions) * Incidence and conditions of occurrence of adverse reactions in the clinical setting * Factors that may affect the safety and effectiveness of Humira
Conditions
Timeline
- Start date
- 2010-10-27
- Primary completion
- 2017-12-28
- Completion
- 2017-12-28
- First posted
- 2011-04-05
- Last updated
- 2019-04-03
- Results posted
- 2019-04-03
Locations
194 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01329380. Inclusion in this directory is not an endorsement.